Actividades asistenciales
SGC STIMULATORS
23/03/2026
Elranatamab
19/02/2026
Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof
24/10/2019 -
<p>The invention relates to new pyridinyl sulfonamide derivatives of the formula (I) wherein R1, A and n are as defined in the description and claims, to their use as medicaments, to...
ELACESTRANT IN COMBINATION WITH ABEMACICLIB IN WOMEN WITH BREAST CANCER
26/11/2019 -
The present disclosure relates to methods of treating breast cancer in a patient, comprising administering to the patient a therapeutic combination comprising elacestrant, or a pharmaceutically...
METHOD AND APPARATUS FOR PROVIDING COGNITIVE BEHAVIOR THERAPY TO PATIENTS WITH TEMPOROMANDIBULAR DISORDER
03/03/2026 -
일 측면에 따른 장치는, 적어도 하나의 메모리; 및 적어도 하나의 프로세서;를 포함하고, 상기 적어도 하나의 프로세서는, 사용자에게 복수의...
5'-O-PHENYLACETYLURIDINE AND THERAPEUTIC USE
16/03/2026
CRISPR-CAS SYSTEM AND USE THEREOF
19/03/2026 -
Provided are a CRISPR-Cas protein, a composition thereof and a use thereof. The composition comprises the protein or a fusion protein, or a nucleic acid molecule encoding same. Also provided is a...
FORMULATIONS OF 19-NOR C3,3- DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF
27/12/2022 -
This invention relates to a 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) and pharmaceutical compositions thereof. Also disclosed herein are methods of making the pharmaceutical...
Compounds and combinations thereof for treating neurological and psychiatric conditions
17/03/2026 -
Dosage forms, drug delivery systems, and methods related to dextromethorphan or improved therapeutic effects are disclosed. Typically, an antidepressant, such as bupropion or a related compound is...
THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT
19/03/2026 -
The present invention relates to therapeutic and/or prophylactic agents for ocular inflammatory disease, which comprise an interleukin 6 (IL-6) receptor inhibitor as an active ingredient.
BCMA-gerichtete CAR-T-Zelltherapie für Multiples Myelom
20/02/2026 -
The present invention relates to the field of pharmaceuticals, gene therapy and medicine, specifically to pharmaceutical compositions of a vector based on recombinant non-enveloped virus, in...
KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
24/11/2023 -
La presente invención se refiere al campo técnico de los sistemas de administración para ingredientes activos agroquímicos o ingredientes activos farmacéuticos. La presente invención se...
Correction: Emerging Therapeutics in Rheumatoid Arthritis
19/10/2023 -
Provided herein are stable aqueous pharmaceutical compositions comprising high concentration formulations of a bispecific epidermal growth factor receptor (EGFR)/hepatocyte growth factor receptor...
COMPOUNDS FOR TARGETING DEGRADATION OF BRUTON'S TYROSINE KINASE
31/10/2023 -
This disclosure relates to compounds of Formula (A): BTK— L— DSM (A) or a pharmaceutically acceptable salt thereof, wherein DSM is a degradation signaling moiety that is covalently attached to...
ANTI CCR8 ANTIBODY THERAPY: BIOMARKERS and COMBINATION THERAPIES
27/12/2022 -
The present invention relates to tools and methods for the generation of antibodies which specifically bind chemokine receptors, such as CC or CXC chemokine receptors. Provided are isolated...
MHC CLASS I CHAIN-RELATED PROTEIN A (MICA)-SPECIFIC ANTIBODIES AND USES THEREOF
14/12/2025 -
The present disclosure relates to the treatment of cancer. In particular, the present disclosure provides novel therapeutic antibodies that target MHC Class I Chain-Related Protein A (MICA) in a...
CODON-OPTIMIZED NUCLEIC ACID ENCODING SMN1 PROTEIN
01/12/2022 -
The present application relates to the field of genetics, gene therapy and molecular biology. More specifically, the present invention relates to an isolated codon-optimized nucleic acid encoding...
Actividades asistenciales
Agroalimentación
Automoción y nueva movilidad
Energía sostenible y eficiente
Materiales avanzados
Medio ambiente y sostenibilidad
Patrimonio natural y cultural
Procesos productivos e industria 4.0
Química y biotecnología
Salud y calidad de vida
Transformación digital



